| CAS NO: | 716313-53-0 |
| 规格: | ≥98% |
| 包装 | 价格(元) |
| 25mg | 电议 |
| 50mg | 电议 |
| 100mg | 电议 |
| 250mg | 电议 |
Maralixibat (formerly SHP-625; LUM-001; lopixibat; Livmarli) is an ileal bile acid transporter inhibitor approved for treatment of cholestatic pruritus associated with Alagille syndrome. It was approved for medical use in the United States in September 2021.
纯度：≥98%
CAS：716313-53-0
m.cnreagent.com